Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |